Mass. lawmakers see support for $1B biotech bill

One of the top lawmakers in Massachusetts is predicting swift passage of a new bill that would provide a billion dollars in incentives to the life sciences industry in the state. The area around Boston is one of the biggest hubs of biotechnology in the world, but Governor Deval Patrick believes that these incentives--including $500 million for new equipment--is needed to safeguard Massachusetts from predators of the economic development world. A host of states--and several countries--have been designing incentives for biotech companies and the research groups that spawn new development projects. The state has done little, until now, to actually support biotech.

- read the report for more

Suggested Articles

Bluebird Bio offered the first glimpse of how its CAR-T follow-up is working in multiple myeloma patients who have tried several other treatments.

Zentalis is coming out of stealth with an $85 million series C, which will propel its lead programs into pivotal trials and broaden its pipeline.

The planned takeover centers on ARQ 531, a BTK inhibitor that triggered durable responses in patients with B-cell malignancies.